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RDRPProtein priming is an important mechanism that many viruses use to initiate genomic DNA or RNA synthesis.
Birnaviruses are the only double-stranded (ds) RNA viruses that use protein priming. The viral-encoded VP1
of birnavirus functions as both a polymerase and a protein primer and is able to undergo self-guanylylation
to acquire a covalently linked rGMP. By employing biochemical assays using recombinant proteins, we have
shown that VP1 self-guanylylation does not require an RNA template but is dependent on divalent metal
ions. VP1 reacts with all four types of rNTPs but strongly prefers rGTP. Unexpectedly, two fatal polymerase
mutants D402A and E421Y, each having an essential catalytic residue mutated and unable to catalyze RNA
synthesis, remain active in self-guanylylation. The guanylylation site was further mapped to the VP1
N-terminal domain. Our results support a mechanism in which VP1 self-guanylylation is catalyzed by a
novel active site different from the polymerase active site.
© 2009 Elsevier Inc. All rights reserved.Introduction
Many viruses initiate terminal nucleic acid synthesis using protein
molecules as primers. These protein primers are known as terminal
protein (TP) in DNA viruses and genome-linked protein (VPg) in RNA
viruses (Paul et al., 1998; Salas, 1991). Among these protein-priming
viruses, many are important causative agents of serious human and
animal diseases such as common colds (rhinovirus), hepatitis
(hepatitis A and B viruses), poliomyelitis meningitis (poliovirus),
acute febrile respiratory disease (adenovirus), and cattle foot-and-
mouth diseases (foot-and-mouth disease virus). Therefore, under-
standing the mechanism of protein-primed viral genome replication
will have important application to the development of new antiviral
therapies for both human and animal diseases.
Birnaviruses (family Birnaviridae) include pathogens of eco-
nomic and environmental importance, such as the infectious bursa
disease virus (IBDV) of the genus Avibirnavirus, infectious pancreatic
necrosis virus (IPNV) and blotched snakehead virus (BSNV) of the
genus Aquabirnavirus, and Drosophila X virus (DXV) of the genus
Entomobirnavirus (Da Costa et al., 2003; Leong et al., 2000). Mature
IBDV virion contains two dsRNA segments, RNA-A and RNA-B, that are
covalently linked to the viral RNA-dependent RNA polymerase (RdRp)
VP1 at the 5′ end. Birnaviruses are the only dsRNA viruses that initiatell rights reserved.RNA synthesis using protein primers. The protein-priming function in
birnaviruses is carried out by the polymerase VP1 itself (Calvert et al.,
1991; Xu et al., 2004), similar to the situation in hepatitis B virus
(HBV) in which the reverse transcriptase (RT) also functions as the
protein primer (Wang and Seeger, 1992; Zoulim and Seeger, 1994).
The ﬁrst step in birnavirus protein priming is the covalent attachment
of a GMP moiety to the hydroxyl group of a tyrosine or serine residue
within the protein-primer molecule. In this initial guanylylation
reaction, the GMP moiety is linked to the protein primer through the
α-phosphate group via a phosphodiester bond, yielding VP1-G, which
can be further guanylylated to produce VP1-GG (Dobos, 1993; Shwed
et al., 2002; Spies and Muller, 1990; Xu et al., 2004). It has been
proposed that the−GGmoiety in VP1-GG binds to the−CC sequence
at the 3′ ends of the viral RNA template during the initiation of both
(+) and (−) RNA synthesis (Magyar et al., 1998; Xu et al., 2004). As
a consequence, the 5′ ends of both the (+) and (−) strands of the
bi-segmented dsRNA genome of birnaviruses are covalently attached
to the viral polymerase VP1. The self-guanylylation activities of
birnavirus VP1 have been demonstrated in vivo using virus-infected
cells as well as in vitro using puriﬁed viral particles (Dobos, 1993;
Shwed et al., 2002). In a more recent study, it has been shown that
recombinant IPNV VP1 is also able to self-guanylylate (Xu et al.,
2004). The birnavirus VP1 guanylylation site residue has been
proposed to be a serine for IBDV and IPNV and a tyrosine for DXV
(Calvert et al., 1991; Dobos, 1993; Xu et al., 2004).
We are interested in elucidating the structural basis of viral protein
priming in genome replication using birnaviruses as a paradigm. We
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containing residues 19 to 810 (Pan et al., 2007) and have shown that
the polymerase active site has a novel topology with the ﬁve essential
polymerase motifs arranged in the permuted order of C-A-B-D-E as
previously predicted (Gorbalenya et al., 2002). In an effort to elucidate
the mechanism of birnavirus VP1 protein priming, we have shown
that puriﬁed recombinant IBDV VP1 is able to self-guanylylate in vitro
in the absence of any template. VP1 polymerase activity, however,
requires an RNA template for both de novo (primer-independent) and
protein-primer-dependent RNA synthesis. Both guanylylation and
polymerization activities require divalent metal ions such as Mg2+
and Mn2+ as cofactors. Much stronger activities were achieved when
Mg2+ was replaced by Mn2+. Nucleotide triphosphate (rNTP)
substrate speciﬁcity assays show that VP1 preferably reacts with
rGTP over other rNTP types. A total of eight VP1 mutants were
generated to probe the VP1 protein-priming mechanism. To our
surprise, two mutants that are completely inactive in RNA synthesis
retain the self-guanylylation activity. Our results suggest that
birnavirus VP1 self-guanylylation is catalyzed by an active site that
does not completely overlap with or may even be different from that
for nucleotide polymerization within the same molecule.
Results
Puriﬁcation of the wild-type and mutant IBDV VP1
IBDV VP1 proteins used in this study were obtained by over-
expression in insect cells using the baculovirus vector (Pan et al.,
2007). A 6× His tag was engineered at the N-terminus to facilitateFig. 1. Self-guanylylation activity of IBDV VP1. (A) Effects of temperature on guanylylation ac
indicated at the bottom as percentage of the guanylylation activity at 37 °C. (B) Time course
10, 15, 30, 80 min and 2, 4, 24 h. Guanylylation activity is indicated as percentage of the guan
activity. All reaction buffers contained 30mMNaCl to keep VP1 soluble. Additional NaCl (0, 10
were performed at 37 °C for 2 h. Guanylylation product is marked as VP1-G/GG to indic
guanylylation reactions were incubated at 37 °C for 2 h in reaction buffers supplementedwith
as percentage of the guanylylation activity at 2 mM Mn2+. (E) Requirements of RNA or div
requirement of divalent metal ions, assays were carried out in 2 mM Mn2+ with (lane 4) opuriﬁcation unless otherwise speciﬁed. The histidine-tagged IBDV
VP1 and all eight mutants (D402A, N403A, S166A, T168A, E421D,
E421Y, E421A, and Δ670-672) were puriﬁed sequentially using nickel
afﬁnity, Heparin afﬁnity, gel ﬁltration, and anion exchange chromato-
graphy. All mutant proteins behaved similarly like the wild-type
protein on all chromatographic columns. VP1 proteins were eluted
from the Superdex-200 gel ﬁltration column as a single peak at the
∼100-kDa position, consistent with VP1 being a monomer. The ﬁnal
puriﬁed protein was at least 95% pure, as overloaded SDS–PAGE gels
did not show any obvious contaminating bands (Pan et al., 2007). The
A280/A260 ratio of such samples was always higher than 2,
suggesting very little, if any, nucleic acids in the sample. Typically,
2 mg of puriﬁed VP1 proteins was obtained from each liter of insect
cell culture. As a control, non-tagged IBDV VP1 had also been obtained
from insect cells. The puriﬁcation of the non-tagged proteins differed
from that of the fusion proteins in that a (NH4)2SO4 precipitation step
was used to replace the Ni-NTA afﬁnity column. The non-tagged
protein behaved identically to the N-terminal His-tagged protein in
both guanylylation and polymerase assays (data not shown). There-
fore, unless otherwise noted, our further self-guanylylation assays
were performed using the His-tagged VP1.
Self-guanylylation activity of IBDV VP1
Recombinant IBDV VP1 exhibits self-guanylylation activity in our
in vitro assays. To remove non-covalently bound nucleotides, all
protein samples were boiled for 5 min before being subjected to
SDS–PAGE. As shown in Fig. 1, VP1 became radio-labeled in the
presence of [α-32P]rGTP. On the other hand, bovine serum albumintivity. Samples were incubated at 4, 10, 22, 37, and 40 °C for 2 h. Guanylylation activity is
of VP1 self-guanylylation. VP1 guanylylation reactions were performed at 37 °C for 3, 5,
ylylation activity of the 24-h reaction. (C) Effects of NaCl and KCl on VP1 guanylylation
, 20, 50, 100, and 200mM) or KCl (0, 10, 20, 50, 100, and 200mM)was added. Reactions
ate that VP1 might contain one or two rGMPs. (D) Effects of Mn2+ and Mg2+. VP1
0.01, 0.1, 1, 2, 6, 10, 20, and 30mMofMn2+ orMg2+. Guanylylation activity is indicated
alent ions. VP1 was pre-treated with RNase A prior to guanylylation assay. To test the
r without (lane 3) 4 mM EDTA.
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radiation above the background level (data not shown). To address
whether RNA template was required for the reaction, VP1 was pre-
treatedwith RNase A to remove any potential contaminating RNA. The
result shows that VP1was able to self-guanylylate equallywell with or
without RNase A treatment (Fig. 1E, lane 1 vs. lane 2). This result
demonstrates that VP1 guanylylation, or at least a basal level of such an
activity, does not require additional viral or host factors. Therefore, like
potyvirus and calicivirus VPg uridylylation, but unlike picornavirus
uridylylation and duck hepatitis B virus (DHBV) deoxyguanylylation
(Anindya et al., 2005; Machin et al., 2001; Puustinen and Makinen,
2004; Wang and Hu, 2002), birnavirus VP1 self-guanylylation is
independent of RNA templates.
When the self-guanylylation reaction of VP1 was carried out at
different temperatures, the highest activity was achieved at 37 °C
(Fig. 1A). Therefore, all reactions were routinely performed at 37 °C
in this study. To test the time-dependent behavior of VP1 self-
guanylylation, puriﬁed VP1 was incubated with [α-32P]rGTP for up to
24 h (Fig. 1B). Signiﬁcant amounts of guanylylated VP1 products
were obtained after 2 h. A prolonged, 24-h incubation produced only
twice as much guanylylated product as that from a 2-h incubation
(Fig. 1B, lane 7 vs. lane 9). For consistency, all of our guanylylation
assays were performed for 2 h unless otherwise indicated.
The concentration of monovalent salts appeared to have profound
effects on VP1 self-guanylylation (Fig. 1C). In order to keep VP1
soluble, 30 mM NaCl was kept in all reaction buffers. When additional
NaCl or KCl was included, VP1 guanylylation activity decreased
dramatically. For example, with an additional 20 mM NaCl, the
activity was reduced to less than 50% of that under the standard
condition (Fig. 1C, lane 1 vs. lane 8). The addition of KCl was slightly
less disruptive compared to NaCl (Fig. 1C).
The effects of divalent metal ions on VP1 guanylylation
As divalent metal ions are essential for the activity of many
polymerases, the effects of various metal ions on the VP1 guanylylation
activity were examined. In these assays, magnesiumwas always used as
the standard metal ion for comparison purposes. Under our assay
conditions, Cu2+ and Cd2+ could not support any detectable guanylyla-
tion activity. While Co2+, Ca2+, and Zn2+ were able to support only
marginal guanylylation activity (data not shown), Mn2+ dramatically
stimulated the guanylylation activity of VP1. To further explore the
effects of Mn2+ on VP1 guanylylation, experiments were performed
using reactionbufferswithvarious concentrations ofMn2+orMg2+(Fig.
1D). Maximal guanylylation activity was obtained at 2 mM Mn2+ and
declinedwhen the concentrationwas above 20mM (Fig. 1D, lanes 1–8).
For Mg2+, the activity also started to decrease with more than 20 mM
Mg2+presumably due to the increase of the total salt concentration in
the buffer, but little difference was observed for concentrations ranging
from 0.01 to 10 mM (Fig. 1D, lanes 9–16). The amount of guanylylated
VP1 products in the presence of 2 mM Mn2+ was about 15 times
more than that using the sameamountofMg2+. Theenhancingeffects of
Mn2+ on protein priming have also been documented for several other
protein-priming viruses (Anindya et al., 2005; Lin et al., 2008;Machin et
al., 2001; Paul et al., 2003; Puustinen and Makinen, 2004).
To further characterize the dependence of VP1 self-guanylylation
on divalent ions, experiments were performed in 2 mM Mn2+ with
and without 4 mM EDTA. In the presence of EDTA, IBDV VP1 could not
be labeled with [α-32P]rGTP (Fig. 1E, lane 3 vs. lane 4). It was also
noticed that very low concentration of Mg2+ or Mn2+ (0.01 mM) was
able to support the VP1 guanylylation activity (Fig. 1D, lanes 1 and 9).
Interestingly, when neither EDTA nor Mg2+/Mn2+ was included in
the buffer, a slight self-guanylylation activity was often observed
(data not shown), presumably due to the presence of certain residual
divalentmetal ions in the reaction solution. The unexpectedweak VP1
guanylylation activity due to the trace amount of metal ions possiblyexplains an earlier report that VP1 guanylylation was Mg2+/Mn2+
independent (Dobos, 1993). Our ﬁndings demonstrate that divalent
metal ion is an essential cofactor for VP1 self-guanylylation. Indeed,
divalent metal ions have been found to be essential for protein
priming in many viruses such as poliovirus (uridylylation), DHBV
(deoxyguanylylation), bacteriophage PRD1 (deoxyguanylylation),
and adenovirus (deoxycytidylylation) (Caldentey et al., 1992; Lichy
et al., 1981; Lin et al., 2008; Paul et al., 2003).
Substrate speciﬁcity of VP1 nucleotidylation
To determine the substrate speciﬁcity of VP1, nucleotidylation
assays were performed using different ribonucleotide triphosphates
(rNTPs). Our results showed that any of the four rNTPs was able to
react with VP1 nucleotidylation, with the preference order of
GNUNCNA (Fig. 2A). At all the concentrations we have tested (from
0.004 to 0.4 μM), VP1 was consistently labeled most efﬁciently with
rGTP (Fig. 2A). The same tendency was also observed when the
nucleotide concentration was further increased to 1.0 mM (data not
shown). Because VP1 was the only viral component included in the in
vitro assays and there was no RNA template present, this slight
preference for rGTP indicates that the substrate binding site located
within VP1 itself possesses some, if not all the motifs for speciﬁc
recognition of the nucleotide substrate. It is interesting to note that
the nucleotidylation of potyvirus VPg also lacks strong substrate
speciﬁcity (Puustinen and Makinen, 2004).
To further examine the substrate speciﬁcity of VP1 nucleotidyla-
tion, competition assays were performed by titrating cold rNTPs into
[α-32P]rGTP. As indicated in Fig. 2B, the VP1 guanylylation reaction
was nearly completely competed by 10× more concentrated cold
rGTP, while VP1 could still be radio-labeled even though cold rUTP
was 1000× more concentrated than [α-32P]rGTP.
The effects of small molecule drugs on VP1 guanylylation
To probe the catalytic mechanism of VP1 self-guanylylation, we
have tested the effects of twomolecules, phosphonoformic acid (PFA),
a pyrophosphate (PPi) analogue, and rifampicin, an RNA polymerase
inhibitor that binds tightly in the RNA exit channel of bacterial RNA
polymerase (Campbell et al., 2001). PFA completely inhibited VP1
self-guanylylation at N0.6 mM concentration, indicating that PPi is
likely a product of the self-guanylylation reaction as we had expected.
By contrast, rifampicin had no effect even at a 1-mM concentration. A
previous report shows that rifampicin also failed to inhibit T7 RNA
polymerase activity (Chamberlin and Ring, 1973). Likewise, IBDV VP1,
an RNA-dependent RNA polymerases, possesses a different structural
fold compared to that of bacterial RNA polymerase and probably does
not bind rifampicin (Fig. 3).
Polymerase activity of IBDV VP1
Using in vitro assays, we have previously shown that IBDV VP1was
able to catalyze RNA synthesis using ssRNA of either IBDV RNA-A or
RNA-B segment as a template (Pan et al., 2007). To facilitate the
characterization of reaction products, an 80-nt ssRNA, which was
derived from the 3′ end of IBDV RNA-A plus-strand, was used as a
template in our polymerase assays. Three product species were
observed on SDS–PAGE at the ∼25-, ∼90-, and ∼110-kDa position,
respectively (Fig. 4A, lane 11). The ∼90-kDa band was located at the
same position as radio-labeled band from the VP1 self-guanylylation
reaction (Fig. 4A, lane 3) and therefore was presumably the self-
guanylylation product VP1-G/GG. The ∼25-kDa band migrated to a
position close to the 100 bp DNA band (Fig. 4A, lane 1) or the 32P-
labled 80-nt ssRNA band (Fig. 4A, lane 2). Like the ∼25-kDa band, the
∼110-kDa band was detected only in the presence of RNA template
(Fig. 4A, lane 3 vs. lanes 4–11). The intensities of the three bands are
Fig. 2. Substrate speciﬁcity for VP1 self-nucleotidylation. (A) VP1 nucleotidylation with different rNTPs. Assays were performed in standard reaction buffer containing [α-32P]rNTPs
(3000 Ci/mmol) at ﬁnal concentrations of 0.004, 0.04, 0.2, or 0.4 μM as indicated. The reference date and the speciﬁcity of all rNTPs were identical, so the activities were directly
comparable. Priming activity is indicated as percentage of the guanylylation activity using 0.4 μM [α-32P]rGTP. Priming product is indicated as VP1-N/NN where N can be any of the
four rNTPs. (B) Substrate competition assay. VP1 self-guanylylation was performed with cold rGTP or rUTP in the amounts of 0, 10×, 100×, 1000×, and 10,000× of the [α-32P]rGTPs
(800Ci/mmol, 10 μCi).
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rGTP was kept 0.2 μM concentration, increasing concentration of
unlabeled rGTP (from 0 to 500 μM) resulted in weaker intensities for
all three product bands (Fig. 4A, lanes 4–8). Similarly, without adding
unlabeled rGTP, increasing concentration of [α-32P] rGTP correlated
with higher intensities for the three bands (Fig. 4A, lanes 8–11),
indicating that the detected signals are [α-32P] rGTP speciﬁc.
To characterize the molecular nature of these products, the
reaction samples were subjected to proteinase K and RNase V1
treatment (Fig. 4B). The results showed that the ∼90-kDa band was
susceptible to proteinase K but resistant to RNase V1, consistentwith it
being the guanylylation product VP1-G/GG. In contrast, the ∼25-kDa
band was easily digested by RNase V1 but resistant to proteinase K,
demonstrating that it was a dsRNA. The ∼110-kDa band is sensitive to
both protease K and RNase V1, suggesting that it is a protein–dsRNA
conjugate and likely to be the protein-primed RNA synthesis product.
Taken together, VP1 exhibits thee different types of activities, namely
the self-guanylylation activity, the primer-dependent RNA synthesis
activity, and the primer-independent RNA synthesis activities, result-
ing in the formation of VP1-G/GG (∼90 kDa), VP1-dsRNA (∼110 kDa),
and the dsRNA (∼25 kDa) products, respectively.
To further verify that the radioactivity associated with the three
products were indeed from rGMP (or α-phosphate) and not from
γ-phosphate, VP1 polymerization assay was carried out in the
presence of [8-3H]rGTP, which has a tritium atom at position 8 of
the purine ring. Similarly, three major products with similarFig. 3. The effects of small molecule drugs on VP1 self-guanylylation. VP1 guanylylation assay
various concentrations. Guanylylation activity is indicated as percentage of the guanylylatiomolecular weights were detected (Fig. 4C, lane 2), indicating that
they all contained the 3H-guanine.
Since our previous polymerization assays were performed using the
plus-strand RNA template, we then asked either VP1was able to synthe-
size RNA using the minus-strand RNA template. An 80-nt RNA fragment
derived from 3′ end of minus-stranded RNA-Awas used for polymeriza-
tion assay, and similar band pattern was obtained (Fig. 4C, lane 3).
In the previous experiment, we have showed that VP1 guanylyla-
tionwas inhibited by high concentrations of monovalent cations (Na+
or K+). We then asked whether the polymerization activity was also
sensitive to monovalent cations. Our results show that RNA synthesis
was also inhibited in the presence of Na+ or K+ at high concentrations
(Fig. 4D). In addition, we have noticed that the ∼25-kDa band (the
product of de novo RNA synthesis activity) is about ∼100 times
stronger than the ∼90- and the ∼110-kDa bands (the products of the
protein-primer-dependent RNA synthesis activity). Details of these
three activities and their dependence on reaction conditions are
currently under investigation.
A chasing experiment was also performed to demonstrate that the
∼110-kDaproduct is indeed a result of protein priming (Fig. 6C).When
radio-labeledguanylylatedVP1was incubatedwith cold rNTP andRNA
template, we observed that a signiﬁcant portion (∼38%) of the ∼90-
kDa radio-labeled VP1 became shifted to the ∼110-kDa position on an
SDS–PAGE gel (Fig. 6C, lane 2 vs. lane 4). A complete shift of the ∼90-
kDa bandwas not observed, possibly due to a strong competition from
the primer-independent RNA synthesis activity as described above.s were performed in the standard reaction buffer in the presence of PFA or rifampicin at
n activity without the inhibitors.
Fig. 4. RNA synthesis by VP1. (A) In vitro RNA synthesis by VP1 using an 80-nt template. In lanes 4–8, various concentrations of cold rGTP were supplemented to the reaction
mixtures containing 0.2 μM of [α-32P]rGTP and 0.5 mM each of ATP, CTP, and UTP (lanes 5–8). In lanes 8–11, the concentration of [α-32P]rGTP varied from 0.05 to 0.8 μM with no
additional cold rGTP. A reaction without RNA template was included as a control (lane 3). The 100-bp DNA ladder (Biolab, lane 1) and the 80-nt RNA template labeled with [γ-32P]
rATP by T4 polynucleotide kinase (lane 2) were used as standards. (B) RNA synthesis product characterization. The reaction products (9 μl) were treated with 1 μl of proteinase K
(20 mg/ml) or 1 μl of RNase V1 (40 U/ml) at room temperature for 30 min. Sample without treatment was used as control. C: control; K: proteinase K; V1: RNase V1. (C)
Conﬁrmation of polymerization products. Polymerization assays were performed in the presence of [α-32P]rGTP or [8-3H]rGTP in the presence of plus-strand RNA template (lanes 1
and 2) or minus-strand RNA template. For the reaction with[8-3H]rGTP, gels were pre-treated with amplifying ﬂuorographic reagent before drying and autoradiography at −70 °C
for 1 month. (D) Effects of NaCl and KCl on VP1 RNA synthesis. Standard reaction buffers contained 30 mMNaCl (lane 1). Additional NaCl (5, 10, 20, and 50 mM, lanes 2–5) or KCl (5,
10, 20, and 50 mM, lanes 6–9) was added. Guanylylation or polymerization activity is indicated as percentage of the activity in the standard buffer.
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Protein priming in many viruses is carried out by two separate
molecules (e.g. VPg and 3DPol in poliovirus). The situation, however, isdifferent in birnaviruses and also DHBV, in which the polymerase and
the protein-priming activities are provided by the same polypeptide.
Despite that the crystal structure of the IBDV VP1 has been solved, the
catalytic relationship between the polymerase active site and the
Fig. 6. IBDV VP1mutants. (A) Self-guanylylation and RNA synthesis by VP1mutants. Same amounts of the wild-type VP1 and the six mutant proteins (S166A, D402A, N403A, E421D,
E421Y, and E421A) were used for in vitro polymerization and guanylylation in the presence of [α-32P]rGTP, and their activities are indicated as the percentage of the activity for the
wild-type protein. (B) Guanylylation activity assays in the presence of DIG-11-UTP. The loading amount of D402A was twice as much as that of other samples. To monitor the
speciﬁcity of DIG labeling, a control was performed using regular rUTP (lane 1). (C) Chasing of guanylylated VP1 into dsRNA products. Wild-type and D402A mutant VP1 were ﬁrst
were guanylylated in the present of [α-32P]rGTP. [α-32P]rGTP was then removed and the puriﬁed guanylylation products were further incubated with RNA template and cold rNTPs.
The amounts of the radioactivity in the two bands, one for VP1-G/GG and the other for VP1-dsRNA, are indicated as percentage of the radioactivity of thewild-type VP1 guanylylation
products. (D) Multiple sequence alignment of three birnaviruses VP1. IBDV: infectious bursa disease virus; IPNV: infectious pancreatic necrosis virus; DXV: Drosophila X virus. The
proposed guanylylation sites are underlined.
Fig. 5. The structure of IBDV VP1. The N-terminal domain is yellow, the C-terminal domain is magenta, the polymerase ﬁngers are blue, the polymerase palm is red, and the
polymerase thumb is green. The ﬁve mutated residues (S166, T168, D402, N403, and E421) are cyan. Also highlighted is a three-residue loop (aa 670–672) that was removed in the
Δ670–672 VP1 mutant.
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structure of IBDV VP1 shows that it has a novel polymerase active site
topology with only two aspartic acid residues and one asparagines
residue at the active site (Garriga et al., 2007; Pan et al., 2007). To
determine the roles of these amino acid residues in VP1 self-
guanylylation and elongative RNA synthesis, we have replaced the
aspartic acid and the asparagine residues of the – 401ADN – tripeptide
(the so-called motif C) with alanines by site-directed mutagenesis
(Fig. 5). The twomutants D402A and N403A folded properly based on
their biochemical behaviors on chromatography columns as men-
tioned above.
When tested by in vitro assays, the D402A mutant completely lost
its RNA polymerase activity, as the ∼25-kDa band and the ∼110-kDa
band, the product of the de novo RNA synthesis (25-kDa band) and
the primer-dependent RNA synthesis, respectively, were not
observed (Fig. 6). Nonetheless, the ∼90-kDa band was detected,
suggesting that D402A might still be capable of self-guanylylation.
The polymerase activity of N403A, on the other hand, decreased to
∼60% of that of the wild type. This result indicates that D402, but not
N403, is essential for the VP1 polymerase activity. Subsequently,
D402A and N403A were used for guanylylation assay in vitro.
Interestingly, both D402A and N403A remained active in self-
guanylylation with a level of activity similar to that of the wild-
type VP1 (Fig. 6A, lane 5 vs. lanes 6–7), suggesting that an intact
polymerase active site was not required for VP1 self-guanylylation.
Unlike the wild-type VP1, guanylylated product of the D402A mutant
could not be chased into dsRNA (Fig. 6C).
To further conﬁrm the speciﬁcity of the detected guanylylation
signal, protein-priming assays were performed using DIG-11-UTP.
DIG-11-UTP has a digoxigenin group covalently attached to position 5
of the pyrimidine ring. As a UTP analog, DIG-11-UTP was able to react
with IBDV VP1 due to the lack of stringent substrate speciﬁcity. As
expected, DIG-labeled VP1 was observed for D402A as well as the
wild-type protein (Fig. 6B). No signal was observed for VP1 priming
with UTP (without the DIG label), indicating that the detected signal
was DIG speciﬁc. Similar results were obtained when the priming
assay was performed using [8-3H] rGTP (data not shown).
The crystal structure of IBDV VP1 shows that the second acidic
amino acid of the polymerasemotif A is a glutamic acid E421 (Fig. 5). In
all other RdRps, the equivalent position is invariantly an aspartic acid,
which helps to select rNTP over dNTP by interacting with the 2′-OH
group of the rNTP substrate. In birnavirus VP1, however, the aspartic
acid is replaced by a glutamic acid residue. To further investigate the
catalytic activity of VP1, E421 was mutated to generate three mutants
E421D, E421Y, and E421A. When the three mutants were used in in
vitro assays, E421D and E421A exhibited similar polymerization (Fig.
6A, lanes 9, 10, and 12) and guanylylation activities (Fig. 6A, lanes 13,
14, and 16) as wild-type VP1. E421Y, however, lost its RNA
polymerization activity (Fig. 6A, lane 9 vs. lane 11) but retained its
guanylylation activity (Fig. 6A, lane 13 vs. lane 15), indicating that
E421, an essential residue for RNA polymerization, is not required for
guanylylation. This result, which is similar to that for the D402A
mutant, further supports the notion that VP1 guanylylation is
independent of the RNA polymerization site. Since the polymerase
active sites of the D402A and E421Ymutantswere no longer capable of
nucleotidyl transfer, VP1 self-guanylylation must be catalyzed by a
separate active site, which may partially overlap with or may be
completely different from the polymerase active site. Such a catalytic
mechanismwould be different from that by DHBV RT, where an intact
polymerase active site was essential for the deoxyguanylylation of the
terminal protein (Wang and Seeger, 1992; Zoulim and Seeger, 1994).
Mapping the VP1 guanylylation site
The guanylylation site of IPNV VP1 has been determined to be S163
using peptide mapping (Xu et al., 2004). Multiple sequence alignmentamong the three birnaviruses superimposes S163 of IPNV VP1 to T168
of IBDV VP1 (Figs. 5 and 6D). However, because phospho-amino acid
determination of labeled IBDV VP1 indicated that the guanylylation
site was a phospho-serine, and because S166 is the only serine found
in this region, S166 was proposed to be the guanylylation site of IBDV
VP1 (Xu et al., 2004). To experimentally conﬁrm the guanylylation site
of IBDV VP1, two VP1 mutants (S166A and T168A) were constructed
and tested in our guanylylation assays. To our surprise, S166A could
still actively self-guanylylate and polymerize nucleotides (Fig. 6A,
lanes 4 and 8). Like the S166Amutant, the T168Amutant also retained
both self-guanylylation and RNA synthesis activities (data not
shown). Our results thus indicate that neither S166 nor T168 is the
guanylylation site of IBDV VP1.
Our previous crystal structure of IBDV VP1 shows that the
beginning of the C-terminal domain forms a 25-residue plug that
inserts deeply into the polymerase active site canyon (Pan et al.,
2007). To probe the function of the C-terminal plug in VP1 self-
guanylylation, guanylylation assays were performed using Δ670-672,
a deletionmutant in which residues – 670SEF – located at the tip of the
plug near the polymerase active site were removed (Fig. 5). The
results showed that the Δ670–672 mutant exhibited activities similar
to that of the wild-type VP1 (data not shown), indicating that the C-
terminal plug probably does not play an important role in the catalysis
of VP1 self-guanylylation.
To further locate the guanylylation site residue in VP1, we
performed an afﬁnity pull-down experiment using partially digested
VP1 samples. Because VP1 contains an N-terminal 6× His tag, Ni-NTA
afﬁnity pull-down enabled us to determine the approximate location
of the guanylylation site residue from the N-terminus by identifying
the shortest N-terminal fragment of VP1 treated with proteases. Our
results showed that Ni-NTA selectively pulled down a ∼20-kDa
fragment that contained the radioactive label [α-32P]rGMP (Supple-
mental Fig. 1). The N-terminal domain (consisting of residues 1 to
167), along with the N-terminal fusion tag (26 residues in total), has a
theoretical molecular weight of 22.2 kDa. Therefore, the guanylyla-
tion site residue most likely resides in the N-terminal domain of VP1.
When the ∼20-kDa fragment was submitted for HPLC/MS/MS,
extensive peptide coverage was found for the polypeptide region
from the N-terminus up to residue 175 (data not shown), consistent
with our interpretation based on the afﬁnity pull-down results. In the
crystal structure of VP1, the N-terminal domain is located at the
upper rear end of the molecule when viewed from the dsRNA exit
channel (Garriga et al., 2007; Pan et al., 2007) (Fig. 5). This domain is
unique to VP1 and is at least 20 Å away from the polymerase active
site.
Discussion
Birnaviruses are the only known dsRNA viruses that use protein
primers and serve as excellent models for structural studies of
protein-priming mechanism. By using in vitro assays and recombinant
proteins, we have systematically characterized the reaction condi-
tions for IBDV VP1 self-guanylylation and RNA synthesis. The
molecule nature of the VP1 catalytic products have been determined
by enzymatic digestion and several different chemical labeling
methods. The catalytic mechanisms of VP1 self-guanylylation and
RNA synthesis have also been probed using small molecule inhibitors
and site-directed mutagenesis.
Our results indicate that IBDV VP1 is most active at 37 °C in the
reaction buffer containing 2 mM Mn2+ and minimal amounts of
monovalent ions. The guanylylation activity of IBDV VP1 is signiﬁ-
cantly stronger in Mn2+ than in Mg2+, as previously reported for
several other RdRps (Alaoui-Lsmaili et al., 2000; Arnold et al., 1999;
Gerber et al., 2001; Yang et al., 2003) and also DHBV RT (Lin,Wan, and
Hu, 2008). Our results also showed that VP1 guanylylation activity
does not require an RNA template, consistent with earlier results
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(Dobos, 1993; Xu et al., 2004). Like birnavirus VP1, potyvirus, and
calicivirus VPg can also be uridylylated by their cognate viral
polymerase in the absence of other viral factors (Anindya et al.,
2005; Machin et al., 2001; Puustinen and Makinen, 2004). In contrast,
protein priming in picornaviruses and DHBV has been shown to
require RNA templates. Stem-loop structures have been predicted in
the non-coding regions of the birnavirus genomes (Boot et al., 1999),
but our results showed that these structural elements, or even the
entire IBDV genetic RNA sequence, are dispensable for VP1 self-
guanylylation in vitro (Pan et al., 2007). The observed differences in
template requirements in the initiation of protein priming in different
viruses may reﬂect the differences in their inherent catalytic
mechanisms and/or catalytic active site conﬁgurations.
In our in vitro assay, both guanylylation and polymerase activities
of IBDV VP1 decreased dramatically when the Na+ or K+
concentration was increased to 100 mM or higher. Since cellular
environments often contain ∼150 mM KCl/NaCl, the question is how
IBDV replicates its genome under physiological conditions. Several
explanations might exist. First, VP1 is reported to function within an
intact viral capsid, in which the chemical environment may be
somewhat different from the cytosol. Second, the interaction of VP1
with other viral proteins (e.g. VP2 and VP3) may affect the response
of VP1 to monovalent ions. Lastly, it is worthwhile to note that the
polymerase activity of the T7 RNA polymerase is also dramatically
reduced by 100 mM KCl, although the optimal polymerization
activity of E. coli RNA polymerase is found between 100 and 200 mM
KCl (Chamberlin and Ring, 1973). Since high concentrations of
monovalent ions reduce both guanylylation and polymerase activ-
ities of VP1, it is reasonable to speculate that the inhibition occurs at
the nucleotide binding step.
IBDV VP1 showed limited speciﬁcity for rGTP and was able to
prime using other nucleotide trisphospates, albeit to lesser extents.
This is different from template-dependent protein-priming viruses,
such as poliovirus and DHBV, inwhich a particular nucleotide is nearly
exclusively preferred (Paul et al., 2000). It has also recently been
reported that DHBV RT shows less dNTP speciﬁcity in the presence of
Mn2+ than in the presence of Mg2+, probably due to the stronger and
thus promiscuous chelating activity of Mn2+ (Lin et al., 2008). More
selective substrate speciﬁcity, however, was not observed for IBDV
VP1whenMg2+was used instead of Mn2+ (data not shown). Another
possibility is that other viral proteins or host factors may be involved
in facilitating rGTP recognition in birnaviruses. Birnavirus VP3 is an
abundant internal protein in IBD virion and it has been shown to
interact with VP1 both in vivo and in vitro (Garriga et al., 2007;
Maraver et al., 2003; Tacken et al., 2002). It has also been reported that
the heat shock protein 90 (hsp90) complex is essential for DHBV RT
priming (Hu and Seeger, 1996). The viral core protein of rotavirus has
also been shown to be important for the viral polymerase activity
(Patton et al., 1997). The potential role of VP3 in VP1 guanylylation is
currently under investigation.
Both primer-dependent and primer-independent RNA synthesis
activities have been observed for IBDV VP1 in vitro, producing
VP1-dsRNA and dsRNA molecules, respectively. Is the primer-
independent polymerase activity physiologically relevant? It has
been shown that both the plus and the minus-strand genomic RNAs
of birnaviruses contain a covalently linked VP1 molecule (Dobos,
1993). In addition, puriﬁed birnavirus samples can support one cycle
of plus-strand RNA synthesis in vitro and these products are covalently
linked to VP1 (Dobos, 1995). Protein-primed RNA synthesis has also
been demonstrated in virus-infected cells (Magyar et al., 1998).
Although these data demonstrate that protein priming may be the
primary or the only mechanism to initiate birnavirus RNA synthesis,
we cannot yet rule out the possibility that primer-independent RNA
synthesis may occur at certain stages of the virus infection cycle.
Meanwhile, regardless of whether primer-independent RNA synthesisis biologically relevant, such activities have been observed under in
vitro conditions for several protein-priming polymerases including the
poliovirus 3Dpol (Richards and Ehrenfeld, 1998). Further experiments
are needed to characterize the effects of different solvent conditions
and viral factors on primer-dependent and primer-independent
activities of IBDV VP1.
In spite of the general expectation that nucleotidylation of protein
primers is catalyzed by the polymerase active site, we made the
surprising ﬁnding that two fatal polymerase mutants D402A and
E421Y both retain the self-guanylylation activity. This result has been
conﬁrmed by independent guanylylation assays using three differ-
ently labeled nucleotide triphosphates, [α-32P]rGTP, [8-3H]rGTP, and
DIG-11-UTP. Our protein samples were highly puriﬁed, as shown by
results from chromatograms and SDS–PAGE, ruling out the possibility
that the radioactive band was due to a contaminating host protein. In
addition, VP1 self-guanylylation can be inhibited by PFA, a pyropho-
sphate analogue, suggesting that self-guanylylation involves a
pyrophosphate side-product as is expected for any nucleotidyl
transfer reaction. With all of our experimental evidence available to
date, we speculate that VP1 may possess another active site
speciﬁcally for self-guanylylation. Indeed, VP1 guanylylation does
not need any RNA template, a distinct difference from the RNA
synthesis reaction it catalyzes. Considering that VP1 self-guanylyla-
tion requires divalent metal ions as a cofactor, it is possible that the
VP1 guanylylation active site also employs acidic residues to anchor
divalent metals, which then activate the hydroxyl group from the
protein primer for the subsequent nucleophilic attack on the
α-phosphate of the incoming GTP, similar to what is seen in the
polymerase active site (Joyce and Steitz, 1994).
Our mutagenesis results show that neither S166 nor T168 is the
protein-priming residue as previously suggested (Xu et al., 2004).
Through protease digestion and afﬁnity pull-down experiments, we
have mapped the guanylylation site residue to the VP1 N-terminal
domain. According to the VP1 crystal structure, the N-terminal
domain, which is unique to VP1, consists of the ﬁrst 167 residues.
This domain is spatially separated from the polymerase active site in
its entirety, further supporting our model in which VP1 self-
guanylylation is catalyzed by a novel active site. Guanylylation of
VP1 by a second VP1 molecule is unlikely because VP1 dimers have
not been found, even at high protein concentrations of up to 5 mg/ml
in gel ﬁltration chromatography. It is possible that the N-terminal
domain undergoes conformational changes after guanylylation,
allowing the guanylyl moiety to bind to the polymerase active site
of the same VP1 or of another VP1 molecule to prime RNA synthesis.
Among all protein-priming RNA viruses, potyvirus is probably the
one that most closely resembles birnavirus in terms of its VPg
nucleotidylation behaviors. For instance, the uridylylation of poty-
virus VPg is independent of RNA template and exhibits only slight
substrate preference for UTP (Anindya et al., 2005; Puustinen and
Makinen, 2004). Poliovirus protein priming, on the other hand,
requires speciﬁc RNA templates. Despite extensive studies on
poliovirus protein priming, two different catalytic mechanisms for
VPg nucleotidylation have been proposed (Ferrer-Orta et al., 2006;
Kamtekar et al., 2006; Schein et al., 2006). Based on evidence from
mutagenesis and structural modeling, Schein et al. (2006) put forward
a surface-catalysis model and proposed that the uridylylation reaction
in polioviruses may occur on a solvent exposed surface of 3DPol. It is
also possible that poliovirus VPg uridylylation is catalyzed at the
polymerase active site. Ferrer-Orta et al. (2006) have shown that the
uridylylated VPg binds to the polymerase active site of 3DPol in a
crystal structure. Non-uridylylated VPg also binds to the polymerase
active site, but the uridylylation site residue Tyr3 is located away from
the polymerase active site, out of reach for the nucleotide substrate
and not suitable for uridylyl transfer (Ferrer-Orta et al., 2006). Thus, in
the absence of pre-uridylylation complex structures, how VPg
nucleotidylation is catalyzed in different RNA viruses still appears to
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polymerase active site is not required for IBDV VP1 self-guanylylation
provides strong evidence that birnaviruses, and maybe some other
RNA viruses, might use a novel active site designated for nucleotidy-
lation during protein priming. We expect that further structural and
biochemical characterization of birnavirus VP1 and its functional
complexes will provide interesting insights into the catalytic
mechanism of protein-primed RNA synthesis.
Materials and methods
Cloning, protein expression, and puriﬁcation
The IBDV (strain D78) VP1 coding region was cloned into
pFastBacHTa (Invitrogen) using primer pairs 5′-AATCCATGGGCAGT-
GACATTTTCAACAGTCC and 5′-ACGCTCGAGTTAGCGGCTCTCCTTTT
between the NcoI and XhoI restriction sites. The resulting plasmid
pFastBacHTa::ibdvvp1 was used as a template to generate plasmids
encoding the VP1 mutants D402A, N403A, S166A, T168A, E421D,
E421Y,E421A, and Δ670-672 by using primer pairs containing the
designated mutations. These plasmids were used to transform
DH10Bac competent cells (Invitrogen) and the resulting recombinant
baculovirus DNA was used to produce recombinant baculoviruses by
transfecting Sf21 insect cells (Invitrogen). Recombinant VP1 con-
tained six histidine residues and a TEV cleavage site at the N-terminus.
IBDV VP1 and the eight mutants described above were each
expressed by infecting Sf21 cells at a multiplicity of infection (MOI) of
2. Infected cells were harvested 48 h post-infection. The cell pellet was
resuspended and sonicated in lysis buffer containing 50 mM Tris–HCl
pH 7.5, 300 mM NaCl, 5 mM imidazole, 10% glycerol, 17 μg/ml PMSF,
1 μg/ml leupeptin, 1 μg/ml pepstatin, and 5 mM β-mercaptoethanol,
and the lysate was clariﬁed by centrifugation at 20,000×g for 20 min.
Recombinant VP1 was puriﬁed by chromatography using a Ni-NTA
column, a HiTrap Heparin-Sepharose column, a Superdex-200
column, and a Mono Q column (Amersham) as previously described
(Pan et al., 2007).
RNA templates
An 80-nt RNA containing the 3′ terminal sequence of the positive
strand of IBDV RNA-A (5′ GUCUCCCGAC ACCACCCGCG CAGGUGUGGA
CACCAAUUCG GCCUUACAAC AUCCCAAAUU GGAUCCGUUC
GCGGGUCCCC) was obtained from in vitro transcription using a
synthetic DNA duplex containing a T7 promoter and the above
sequence of interest. RNA synthesis was carried out using the
MEGAscript in vitro transcription kit (Ambion). Following the
transcription reaction, the DNA template was removed by digestion
with RNase-free DNase I and RNA was puriﬁed by phenol extraction
and ethanol precipitation using a standard procedure. The puriﬁed
RNA was suspended in nuclease-free distilled water containing 2 U/μl
RNasin (Promega) and aliquots were stored at −70 °C. The quantity
and the quality of RNA were estimated by agarose gel electrophoresis
followed by ethidium bromide staining. The 80-nt RNAwas used in all
assays described in this study unless otherwise speciﬁed.
In vitro self-guanylylation and polymerization assays
In vitro guanylylation assaywas performed as previously described
with minor modiﬁcations (Dobos, 1993). Brieﬂy, pure VP1 protein
samples (ca. 0.2 μM) were incubated in a 10-μl reaction mixture
containing 20mMTris–HCl (pH 8.0), 5mMMgCl2, 2mMMnCl2, 4 mM
dithiothreitol (DTT), 1×proteinase inhibitor cocktail (Roche), and0.1%
(v/v) NP-40. Unless otherwise indicated, the mixture was supple-
mented with 10 μCi of [α-32P]rGTP (3000 Ci/mmol, MP Biomedicals).
In vitro polymerization assay was performed using procedures
similar to the guanylylation assay, with several additional compo-nents including rNTPs mixture (0.01 mM GTP, 0.5 mM each of ATP,
CTP, UTP), RNasin (0.4 U/μl), and RNA template (ca. 1 μM). The RNA
template was the 80-nt +ssRNA as described above. The samples
were incubated at 37 °C for 2 h . The reactions were stopped bymixing
with equal volumes of 2× SDS sample buffer and boiled for 5 min
before being subjected to SDS–PAGE. The gel was then dried and
subjected to autoradiography and phosphor-imaging quantiﬁcation.
Substrate competition assays
The competition assays were performed by supplemented compe-
titor nucleotides into the guanylylation assays. In brief, 10 μCi [α-32P]
GTP (speciﬁc activity 800 Ci/mmol, MP Biomedicals) was premixed
with serial concentrations of cold GTP or UTP in 1× guanylylation
buffer. 10 μg IBDV VP1 was then added into each sample and mixed,
followed by 10-min incubation in a 37 °C sand bath. The samples were
then treated with 2× SDS sample buffer, boiled, and subjected to
electrophoresis and autoradiography.
Characterization of VP1 reaction products
To conﬁrm the presence of nucleotide base in the labeled VP1
products, guanylylation and polymerization assays were performed
as described above except that [α-32P]rGTP was replaced with
5 μM [8-3H]rGTP (5.10 Ci/mmol, GE Healthcare) or 100 μM DIG-
11-UTP (3.5 mM, Roche). For [8-3H]rGTP labeling, the SDS–PAGE
gel was treated with amplifying ﬂuorographic reagent NAMP-100
(GE Healthcare) before drying and autoradiography at −70 °C. For
DIG-11-UTP labeling, the reaction products in the gels were electro-
transferred to a hybond-N+ nylon membrane (GE Healthcare). The
DIG-labeled products were visualized by an enzyme immunoassay
using anti-digoxigenin antibody and the chemiluminescent substrate
CSPD (Roche).
To characterize the molecular nature of the reaction products,
[α-32P]rGTP-labeled samples were treated with RNase-free protei-
nase K (Roche) or RNase V1 (Ambion). Thereafter, the treated samples
were resolved by SDS–PAGE and detected by autoradiography.
Chasing of guanylylated VP1 to dsRNA products
To examine whether the guanylylated VP1 can be used to prime
RNA synthesis, polymerase assays were performed using cold rNTPs
and labeled, guanylylated VP1. First, VP1 guanylylation was
performed as described above in 1× guanylylation buffer (20 mM
Tris–HCl pH 8.0, 5 mMMgCl2, 2 mMMnCl2, 4 mM DTT, 1× proteinase
inhibitor cocktail, and 0.1% (v/v) NP-40 ) supplemented with [α-32P]
rGTP. Thereafter, [α-32P]rGTP was removed by passing guanylylated
VP1 through a NICK column (GE health) that was pre-equilibrated
with 10 column volumes of 1× guanylylation buffer. Puriﬁed VP1 was
further incubated for 2 h in the 1× polymerization buffer (20 mM
Tris–HCl pH 8.0, 5 mMMgCl2, 2 mMMnCl2, 4 mM DTT, 1× proteinase
inhibitor cocktail, RNasin (0.4 U/μl), and 0.1% (v/v) NP-40), 0.5mM of
each ATP, CTP, UTP, and GTP, and RNA template (ca. 2 μM). The
reactions samples were subjected to 12% SDS–PAGE as described
above.
Mapping guanylylation site by protease digestion and afﬁnity
puriﬁcation
N-terminal His-tagged VP1 was guanylylated with [α-32P]rGTP
and partially digested with trypsin at 1:500 mass ratio overnight at
room temperature. The trypsin-treated sample was then incubated
with Ni-NTA resin in the guanylylation reaction buffer for 4 h, and the
resin was subsequently washed with the same buffer containing 1%
Triton X-100, 100mMNaCl, and 20mM imidazole and elutedwith the
same buffer containing 100 mM NaCl and 250 mM imidazole. The
96 J. Pan et al. / Virology 395 (2009) 87–96samples were analyzed on a 12.5% SDS–PAGE gel and visualized by
autoradiography.
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